Your request to link to rcsb for Tryptase

• 1LTO: human alpha1-tryptase (10.1016/S0022-2836(02)00625-3 )
• 2BM2: human beta-ii tryptase in complex with 4-(3-aminomethyl-phenyl)- piperidin-1-yl-(5-phenethyl- pyridin-3-yl)-methanone (10.1016/J.BMC.2005.02.014 )
• 2F9N: crystal structure of the recombinant human alpha i tryptase mutant k192q/d216g in complex with leupeptin (10.1016/J.JMB.2005.12.037 )
• 2F9O: crystal structure of the recombinant human alpha i tryptase mutant d216g (10.1016/J.JMB.2005.12.037 )
• 2F9P: crystal structure of the recombinant human alpha i tryptase mutant d216g in complex with leupeptin (10.1016/J.JMB.2005.12.037 )
• 2FPZ: human tryptase with 2-amino benzimidazole (10.1021/BI060173M )
• 2FS8: human beta-tryptase ii with inhibitor cra-29382 (10.1021/BI060173M )
• 2FS9: human beta tryptase ii with inhibitor cra-28427 (10.1021/BI060173M )
• 2FWW: human beta-tryptase ii complexed with 4-piperidinebutyrate to make acylenzyme (10.1021/BI060173M )
• 2FXR: human beta tryptase ii complexed with activated ketone inhibitor cra- 29382 (10.1021/BI060173M )
• 2GDD: human beta ii tryptase with inhibitor cra-27592
• 2ZA5: crystal structure of human tryptase with potent non-peptide inhibitor (10.1016/J.BMCL.2008.01.093 )
• 2ZEB: potent, nonpeptide inhibitors of human mast cell tryptase (10.1016/J.BMCL.2008.01.093 )
• 2ZEC: potent, nonpeptide inhibitors of human mast cell tryptase (10.1016/J.BMCL.2008.01.093 )
• 3V7T: crystal structure of human beta-tryptase complexed with a synthetic inhibitor with a tropanylamide scaffold (10.1016/J.BMCL.2011.12.127 )
• 4A6L: beta-tryptase inhibitor (10.1016/J.BMCL.2011.11.119 )
• 4MPU: human beta-tryptase co-crystal structure with (6s,8r)-n,n'-bis[3-({4- [3-(aminomethyl)phenyl]piperidin-1-yl}carbonyl)phenyl]-8-hydroxy-6- (1-hydroxycyclobutyl)-5,7-dioxaspiro[3.4]octane-6,8-dicarboxamide (10.1021/ACSMEDCHEMLETT.8B00204 )
• 4MPV: human beta-tryptase co-crystal structure with (2r,4s)-n,n'-bis[3-({4- [3-(aminomethyl)phenyl]piperidin-1-yl}carbonyl)phenyl]-4-hydroxy-2- (2-hydroxypropan-2-yl)-5,5-dimethyl-1,3-dioxolane-2,4-dicarboxamide (10.1021/ACSMEDCHEMLETT.8B00204 )
• 4MPW: human beta-tryptase co-crystal structure with [(1,1,3,3- tetramethyldisiloxane-1,3-diyl)di-1-benzofuran-3,5-diyl]bis({4-[3- (aminomethyl)phenyl]piperidin-1-yl}methanone) (10.1159/000492078 )
• 4MPX: human beta-tryptase co-crystal structure with [(1,1,3,3- tetramethyldisiloxane-1,3-diyl)di-1-benzothiene-4,2-diyl]bis({4-[3- (aminomethyl)phenyl]piperidin-1-yl}methanone)
• 4MQA: human beta-tryptase co-crystal structure with {(1,1,3,3- tetramethyldisiloxane-1,3-diyl)bis[5-(methylsulfanyl)benzene-3,1- diyl]}bis({4-[3-(aminomethyl)phenyl]piperidin-1-yl}methanone)
• 5F03: tryptase b2 in complex with 5-(3-aminomethyl-phenoxymethyl)-3-[3-(2- chloro-pyridin-3-ylethynyl)-phenyl]-oxazolidin-2-one; compound with trifluoro-acetic acid (10.1021/ACS.JMEDCHEM.5B01875 )
• 5WI6: human beta-1 tryptase mutant ile99cys (10.1074/JBC.M117.812016 )
• 6O1F: complex between soybean trypsin inhibitor beta1-tryptase and a humanized fab (10.1016/J.CELL.2019.09.009 )
• 6P0P: human beta-tryptase co-crystal structure with 5-{4-[3-(aminomethyl) phenyl]piperidine-1-carbonyl}-2-(3'-{4-[3-(aminomethyl) phenyl]piperidine-1-carbonyl}-[1,1'-biphenyl]-3-yl)-2-hydroxy-2h-1,3, 2-benzodioxaborol-2-uide (10.1021/ACS.JMEDCHEM.9B01689 )
• 6VVU: anti-tryptase fab e104.v1 bound to tryptase (10.1038/S41467-020-20143-X )